BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND RNF43, DKFZp781H02126, 54894, Q68DV7, URCC, RNF124, MGC125630, FLJ20315, DKFZp781H0392 AND Prognosis
6 results:

  • 1. Pan-cancer analysis identifies rnf43 as a prognostic, therapeutic and immunological biomarker.
    Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
    Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Spatially restricted tumour-associated and host-associated immune drivers correlate with the recurrence sites of pancreatic cancer.
    Karamitopoulou E; Wenning AS; Acharjee A; Zlobec I; Aeschbacher P; Perren A; Gloor B
    Gut; 2023 Aug; 72(8):1523-1533. PubMed ID: 36792355
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Patients deriving long-term benefit from immune checkpoint inhibitors demonstrate conserved patterns of site-specific mutations.
    Principe DR
    Sci Rep; 2022 Jul; 12(1):11490. PubMed ID: 35798829
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Life expectancy in older adults with advanced cancer: Evaluation of a geriatric assessment-based prognostic model.
    Lund JL; Duberstein PR; Loh KP; Gilmore N; Plumb S; Lei L; Keil AP; Islam JY; Hanson LC; Giguere JK; Vogel VG; Burnette BL; Mohile SG
    J Geriatr Oncol; 2022 Mar; 13(2):176-181. PubMed ID: 34483079
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal cancer.
    Pietrantonio F; Di Nicolantonio F; Schrock AB; Lee J; Tejpar S; Sartore-Bianchi A; Hechtman JF; Christiansen J; Novara L; Tebbutt N; FucĂ  G; Antoniotti C; Kim ST; Murphy D; Berenato R; Morano F; Sun J; Min B; Stephens PJ; Chen M; Lazzari L; Miller VA; Shoemaker R; Amatu A; Milione M; Ross JS; Siena S; Bardelli A; Ali SM; Falcone A; de Braud F; Cremolini C
    J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29370427
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled urcc CCOP study.
    Peoples AR; Bushunow PW; Garland SN; Heckler CE; Roscoe JA; Peppone LL; Dudgeon DJ; Kirshner JJ; Banerjee TK; Hopkins JO; Dakhil SR; Flannery MA; Morrow GR
    Support Care Cancer; 2016 Mar; 24(3):1339-47. PubMed ID: 26329396
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.